Skip to search formSkip to main contentSkip to account menu

sargramostim plasmid DNA melanoma vaccine adjuvant

Known as: GM-CSF plasmid DNA melanoma vaccine, GM-CSF plasmid DNA melanoma vaccine adjuvant 
A vaccine adjuvant consisting of a plasmid DNA encoding sargramostim (a granulocyte macrophage-colony stimulating factor). Upon administration… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Microneme protein 8 (MIC8) is considered a new essential invasion factor in Toxoplasma gondii. In the present study, a… 
2009
2009
Prostate stem cell antigen (PSCA) is a cell surface antigen expressed in normal human prostate and over expressed in prostate… 
2005
2005
Plasmid vector is increasingly applied to gene therapy or gene vaccine. The production of plasmid pCMV-AP3 for cancer gene… 
2003
2003
ABSTRACT Proteus mirabilis NEL-1 was isolated from a urine sample of a patient hospitalized in a long-term care facility. Strain… 
Highly Cited
2002
Highly Cited
2002
ABSTRACT A genomic analysis of the Bacillus anthracis virulence plasmid pXO1, aimed at identifying potential vaccine candidates… 
Highly Cited
1996
Highly Cited
1996
Lower responsiveness and higher susceptibility to tolerance are the two main characteristics of neonatal immunity that limit the… 
1994
1994
Anthrax is an infectious disease that has afflicted humans and their domestic livestock since ancient times. Although in many… 
1983
1983
Plasmid pRK419, a derivative of the naturally occurring antibiotic resistance plasmid R6K, contains the pir gene that codes for…